Immune checkpoint inhibitors are a class of cancer immunotherapy that work by blocking proteins that inhibit the immune system's ability to attack cancer cells. By inhibiting these checkpoints, these therapies enhance the immune response against tumors, leading to improved outcomes in various cancers